Back
Day Range
$21.36
$22.32
52-Week Range
$17.56
$48.45
Volume
1,129
50D / 200D Avg
$24.69
/
$33.17
Prev Close
$22.32
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5.1 | 0.3 |
| P/B | 7.9 | 2.9 |
| ROE % | -249.8 | 3.7 |
| Net Margin % | -41.3 | 3.8 |
| Rev Growth 5Y % | 197.9 | 10.0 |
| D/E | 6.3 | 0.2 |
Analyst Price Target
Hold
$48.00
+115.1%
Low: $45.00
High: $51.00
Forward EPS
-$7.50
Est. Revenue
1 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$8.88
-$16.59 – -$3.03
|
2.4 B | 1 |
| FY2028 |
-$10.81
-$20.19 – -$3.69
|
1.5 B | 1 |
| FY2027 |
-$7.17
-$13.39 – -$2.45
|
1.2 B | 1 |
Key Takeaways
Revenue grew 197.91% annually over 5 years — strong growth
Debt/Equity of 6.32 — high leverage
Negative free cash flow of -135.65M
PEG of 0.26 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 143.86%
Capital efficient — spends only 2.48% of revenue on capex
Growth
Revenue Growth (5Y)
197.91%
Revenue (1Y)341.77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-249.80%
ROIC-14.35%
Net Margin-41.34%
Op. Margin-37.70%
Safety
Debt / Equity
6.32
Current Ratio1.26
Interest Coverage-5.74
Valuation
P/E Ratio
-5.12
P/B Ratio7.85
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 341.77% | Revenue Growth (3Y) | 116.25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 197.91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 980.65M | Net Income (TTM) | -405.43M |
| ROE | -249.80% | ROA | -15.49% |
| Gross Margin | 97.03% | Operating Margin | -37.70% |
| Net Margin | -41.34% | Free Cash Flow (TTM) | -135.65M |
| ROIC | -14.35% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 6.32 | Current Ratio | 1.26 |
| Interest Coverage | -5.74 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -5.12 | P/B Ratio | 7.85 |
| P/S Ratio | 2.12 | PEG Ratio | 0.26 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.07B | Enterprise Value | 2.51B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 980.65M | 221.98M | 209.71M | 27.91M | 12.45M |
| Net Income | -405.43M | -925.64M | -882.92M | -782.42M | -677.61M |
| EPS (Diluted) | -5.36 | -52.48 | -53.60 | -49.12 | -50.24 |
| Gross Profit | 951.57M | 191.44M | 187.71M | 24.58M | 10.48M |
| Operating Income | -369.73M | -872.64M | -849.81M | -869.84M | -663.94M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2.62B | 2.50B | 2.83B | 2.94B | 1.73B |
| Total Liabilities | 2.34B | 2.43B | 2.42B | 1.71B | 884.42M |
| Shareholders' Equity | 264.19M | 60.42M | 408.66M | 1.23B | 846.62M |
| Total Debt | 1.67B | 1.80B | 1.79B | 1.08B | 529.70M |
| Cash & Equivalents | 1.24B | 1.07B | 1.48B | 1.71B | 1.02B |
| Current Assets | 1.47B | 1.34B | 1.64B | 1.89B | 1.08B |
| Current Liabilities | 1.17B | 934.17M | 881.15M | 361.11M | 276.15M |